These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24644555)

  • 1. The amide of galacturonic acid with lysine as an immunodominant component of the lipopolysaccharide core region from Proteus penneri 42 strain.
    Palusiak A; Maciejewska A; Ługowski C; Różalski A
    Acta Biochim Pol; 2014; 61(1):129-32. PubMed ID: 24644555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and epitope specificity of the O-specific polysaccharide of Proteus penneri strain 12 (ATCC 33519) containing the amide of D-galacturonic acid with L-threonine.
    Sidorczyk Z; Swierzko A; Knirel YA; Vinogradov EV; Chernyak AY; Kononov LO; Cedzynski M; Rozalski A; Kaca W; Shashkov AS
    Eur J Biochem; 1995 Jun; 230(2):713-21. PubMed ID: 7541754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological classification and epitope specificity of Proteus vulgaris TG 251 from Proteus serogroup O65.
    Zych K; Kołodziejska K; Drzewiecka D; Perepelov AV; Knirel YA; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):187-91. PubMed ID: 17557147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and immunochemical studies on the lipopolysaccharide of the 'T-antigen'-containing mutant Proteus mirabilis R14/1959.
    Bartodziejska B; Radziejewska-Lebrecht J; Lipinska M; Knirel YA; Kononov LO; Chernyak AY; Mayer H; Rozalski A
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):113-21. PubMed ID: 8731019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and epitope characterisation of the O-specific polysaccharide of Proteus mirabilis O28 containing amides of D-galacturonic acid with L-serine and L-lysine.
    Radziejewska-Lebrecht J; Shashkov AS; Vinogradov EV; Grosskurth H; Bartodziejska B; Rozalski A; Kaca W; Kononov LO; Chernyak AY; Mayer H
    Eur J Biochem; 1995 Jun; 230(2):705-12. PubMed ID: 7541753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the O-polysaccharide and serological studies of the lipopolysaccharide of Proteus penneri 60 classified into a new Proteus serogroup O70.
    Zych K; Perepelov A; Baranowska A; Zabłotni A; Shashkov AS; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):351-6. PubMed ID: 15708308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and serological characterization of an Nepsilon-[(R)-1-carboxyethyl]-L-lysine-containing O-chain of the lipopolysaccharide of Proteus mirabilis O13.
    Swierzko AS; Cedzyński M; Ziółkowski A; Senchenkova SN; Perepelov AV; Knirel YA; Kaca W
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):163-9. PubMed ID: 11348021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and serological studies of the O-polysaccharide of Proteus penneri 75 Epitopes and subgroups of Proteus serogroup O73.
    Zych K; Perepelov AV; Baranowska A; Zabłotni A; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):141-8. PubMed ID: 15681143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of Proteus penneri lipopolysaccharides into core region serotypes.
    Palusiak A
    Med Microbiol Immunol; 2016 Dec; 205(6):615-624. PubMed ID: 27469376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the O-polysaccharide of Proteus penneri 28 and Proteus vulgaris O31 and classification of P. penneri 26 and 28 in Proteus serogroup O31.
    Kondakova AN; Zych K; Senchenkova SN; Bartodziejska B; Shashkov AS; Knirel YA; Rozalski AA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2003 Oct; 39(1):87-93. PubMed ID: 14557001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structure of a new lysine-containing O-specific polysaccharide from Proteus mirabilis O26].
    Shashkov AS; Toukach FV; Paramonov NA; Senchenkova SN; Katsa V; Knirel' IuA
    Biokhimiia; 1996 Jan; 61(1):24-33. PubMed ID: 8679775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological classification and epitope specificity of Proteus penneri S29 lipopolysaccharide.
    Zych K; Siwińska M; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2005; 53(6):540-5. PubMed ID: 16407787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures.
    Kaca W; Glenska J; Lechowicz L; Grabowski S; Brauner A; Kwinkowski M
    Biochemistry (Mosc); 2011 Jul; 76(7):851-61. PubMed ID: 21999547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the O-polysaccharide of Proteus mirabilis CCUG 10705 (OF) containing an amide of D-galacturonic acid with L-alanine.
    Perepelov AV; Zabłotni A; Shashkov AS; Knirel YA; Sidorczyk Z
    Carbohydr Res; 2006 Aug; 341(11):1969-74. PubMed ID: 16697996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of human antibodies binding with smooth and rough LPSs from Proteus mirabilis O3 strains S1959, R110, R45.
    Gleńska-Olender J; Durlik K; Konieczna I; Kowalska P; Gawęda J; Kaca W
    Antonie Van Leeuwenhoek; 2017 Nov; 110(11):1435-1443. PubMed ID: 28889208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of synthetic antigens in studies of antigenic specificity of Proteus mirabilis 027 lipopolysaccharide].
    Krajewska-Pietrasik D; Cherniak AY; Rózalski A
    Med Dosw Mikrobiol; 1995; 47(3-4):169-76. PubMed ID: 8833928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the O-specific polysaccharide of the bacterium Proteus mirabilis O13 containing a novel component: an amide of D-galacturonic acid with N(epsilon)-(1-carboxyethyl)lysine.
    Shashkov AS; Toukach FV; Senchenkova SN; Ziolkowski A; Paramonov NA; Kaca W; Knirel YuA ; Kochetkov NK
    Biochemistry (Mosc); 1997 May; 62(5):509-13. PubMed ID: 9275291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and serological classification of a collection of Proteus penneri clinical strains.
    Drzewiecka D; Zych K; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2004; 52(2):121-8. PubMed ID: 15179326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and serological studies of the O-antigen of the bacterium Proteus mirabilis OXK (serogroup O3) used in the Weil-Felix test.
    Swierzko AS; Cedzynski M; Knirel YuA ; Senchenkova SN; Kocharova NA; Shashkov AS; Amano KI; Kyohno K; Kaca W
    Biochemistry (Mosc); 1997 Jan; 62(1):21-7. PubMed ID: 9113725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of two different kinds of sera against the Proteus penneri lipopolysaccharide core region in search of epitopes determining cross-reactions with antibodies.
    Palusiak A; Dzieciatkowska M; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2008; 56(2):135-40. PubMed ID: 18373243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.